Skip to navigation Skip to content



New Strategy for Myelin Repair Targeted by Society-Funded Team

May 10, 2021

Researchers at the University of Buffalo have identified “SULF2,” a molecule involved in cell signaling, as a possible target for strategies to promote the repair of myelin, the substance that surrounds nerve fibers and is damaged in MS. SULF2 is found at high levels in brain lesions in people with MS; when SULF2 is deleted from MS mouse models, myelin repair is accelerated.

The team also reports that PI-88, a SULF2-blocker now in clinical trials to treat cancer, improves repair in mice with damaged myelin. This research was supported in part by the National MS Society, and the team leveraged these results to gain funding from the Department of Defense’s MS Research Program to continue exploring whether PI-88 has potential as a myelin repair treatment to restore function in MS.

Read more from the University at Buffalo

Read the scientific publications on this research in Nature Communications and The Journal of Neuroscience

About Multiple Sclerosis

Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.


© 2022 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.